Up­dat­ed: Leena Gand­hi leaves Dana-Far­ber for check­point in­hibitor biotech

Im­muno-on­col­o­gy pi­o­neer Leena Gand­hi is on the move once again.

Gand­hi is de­part­ing the Dana-Far­ber In­sti­tute to be­come chief med­ical of­fi­cer at Next­Point Ther­a­peu­tics, a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER